Crypto Price Forecast: Bitcoin, PI & Ethereum - European Summary September 29

Digital assets surge as institutional money floods the market

Bitcoin breaks through resistance levels while Ethereum's upgrade fuels bullish sentiment

PI Network continues its steady climb despite regulatory headwinds

European traders drive volume as traditional finance finally catches crypto fever - about five years too late for the early adopters who actually understand the technology

Market momentum suggests this isn't another false dawn but sustained institutional adoption

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

President Trump didn’t provide a comment alongside the video. However, the more holistic approach to medical treatment aligns with the stances of the current administration. A big reason for that is the potential saved costs from adopting CBD as a treatment for seniors. According to The Commonwealth Project video, the integration of cannabis into the healthcare sector could result in annual cost savings of nearly $64 billion.

With that kind of potential, it makes sense that President Trump WOULD be interested in adopting CBD into the healthcare sector. The senior U.S. population was last recorded at over 61 million people, making up roughly 18% of the country’s population. Reducing the cost to treat them could be a major boon to the U.S. government, which covers U.S. citizens aged 65 and older.

What This Means for Cannabis Stocks

President Trump’s post about the benefits of CBD is a positive catalyst for cannabis stocks. As such, many stocks in this sector rallied on Monday, likely in hopes of increased CBD use and the potential for the U.S. government to officially adopt the hemp product into the healthcare system.

Here are a few of the cannabis stocks seeing the biggest gains today.

• Canopy Growth (CGC) stock surged 11.94%.
• Corbus Pharmaceuticals (CRBP) stock gained 1.98%.
• Scotts Miracle-Gro Company (SMG) stock rose 1%.
• Jazz Pharmaceuticals (JAZZ) stock increased 0.76%.
• Constellation Brands (STZ) stock was up 0.38%.

Which Cannabis Stock Is the Best Investment?

Turning to the TipRanks stock comparison tool, traders can see which cannabis stocks analysts prefer. Of the five mentioned above, Corbus Pharmaceuticals and Jazz Pharmaceuticals have consensus Strong Buy ratings. Canopy Growth, Scotts Miracle-Gro Company, and Constellation Brands all have consensus Moderate Buy ratings.

CGC is the stock with the highest growth potential at 328.36%, followed by CRBP at 259.21%, JAZZ at 45.67%, STZ at 29.22%, and ABBV at 7.46%.